Different methods for trying vaginal delivery

Comparision of Misoprostol versus sequential administration of Mifepristone and Misoprostol in Medical Termination of Pregnancy

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2022/04/042164

Enrollment

210

Registered

2022-04-26

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O046- Delayed or excessive hemorrhage following (induced) termination of pregnancy

Interventions

Control Intervention1: GROUP A: Sixty one purposively selected cases will receive tablet misoprostol 600 microgram start placed per vaginally followed by 400 microgram misoprostol tablet placed per

Eligibility

Inclusion criteria

Inclusion criteria: All cases those will fulfil indication of Medical Termination of Pregnancy, as per guidelines of MTP Act of 1971.

Exclusion criteria

Exclusion criteria: Scarred uterus Ectopic pregnancy Grand multipara Contraindications to misoprostol and mifepristone

Design outcomes

Primary

Measure	Time frame
complete expulsion of product of conception within 24hrs of the first dose of misoprostolTimepoint: complete expulsion of product of conception within 24hrs of the first dose of misoprostol	—

Secondary

Measure	Time frame
induction abortion interval will be measured from the time of administration of first dose of misoprostol to the time of complete abortion. The need of analgesics and volume of blood loss will be estimated clinically.Timepoint: after 24 hours induction	—

Countries

India

Contacts

Public ContactDr Shwetha D

Gadag Institute of Medical Sciences,Gadag

hanumantvn.1210@gmail.com9448001054

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026